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Abstract: Our recent study identified seven key microRNAs (miR-8066, 5197, 3611, 3934-3p, 
1307-3p, 3691-3p, 1468-5p) similar between SARS-CoV-2 and the human genome, pointing at 
miR-related mechanisms in viral entry and the regulatory effects on host immunity. To identify 
the putative roles of these miRs in zoonosis, we assessed their conservation, compared with hu-
mans, in some key wild and domestic animal carriers of zoonotic viruses, including bat, pangolin, 
pig, cow, rat, and chicken. Out of the seven miRs under study, miR-3611 was the most strongly 
conserved across all species; miR-5197 was the most conserved in pangolin, pig, cow, bat, and rat; 
miR-1307 was most strongly conserved in pangolin, pig, cow, bat, and human; miR-3691-3p in 
pangolin, cow, and human; miR-3934-3p in pig and cow, followed by pangolin and bat; miR-1468 
was most conserved in pangolin, pig, and bat; while miR-8066 was most conserved in pangolin 
and pig. In humans, miR-3611 and miR-1307 were most conserved, while miR-8066, miR-5197, 
miR-3334-3p and miR-1468 were least conserved, compared with pangolin, pig, cow, and bat. 
Furthermore, we identified that changes in the miR-5197 nucleotides between pangolin and hu-
man can generate three new miRs, with differing tissue distribution in the brain, lung, intestines, 
lymph nodes, and muscle, and with different downstream regulatory effects on KEGG pathways. 
This may be of considerable importance as miR-5197 is localized in the spike protein transcript 
area of the SARS-CoV-2 genome. Our findings may indicate roles for these miRs in viral–host 
co-evolution in zoonotic hosts, particularly highlighting pangolin, bat, cow, and pig as putative 
zoonotic carriers, while highlighting the miRs’ roles in KEGG pathways linked to viral patho-
genicity and host responses in humans. This in silico study paves the way for investigations into 
the roles of miRs in zoonotic disease. 
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1. Introduction 
The COVID-19 pandemic is caused by the severe acute respiratory syndrome coro-
navirus-2 (SARS-CoV-2), a zoonotic virus, which belongs to the betacoronavirus family. 
While a number of zoonotic hosts have been suggested that may possibly not show dis-
ease symptoms [1], SARS-CoV-2 causes significant pathogenicity in humans due to al-
terations in inflammation-related pathways, including some resulting in exacerbated 
inflammatory responses, vascular responses, cutaneous manifestations [2], extensive 
lung pathology, cardiovascular and cardiomyopathy [3–5], kidney damage [6,7], gas-
trointestinal involvement [8], as well as a wide range of neurological conditions includ-
ing stroke, encephalopathy, encephalitis, central nervous system (CNS) vasculitis and 
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acute neuropathies [9–11]. The SARS-CoV-2 genome contains 14 open reading frames 
(ORFs), preceded by transcriptional regulatory sequences (TRSs), while the two main 
transcriptional units, ORF1a and ORF1ab, encode replicase polyprotein 1a (PP1a) and 
polyprotein 1ab (PP1ab), respectively (Figure 1A). The largest polyprotein PP1ab embeds 
non-structural proteins (NSP1-16), which form the complex replicase machinery. This 
includes enzyme activities that are rare or absent in other families of positive-stranded (+) 
RNA viruses. The viral genomes encode four structural proteins, called spike (S), enve-
lope (E), membrane (M), and nucleocapsid (N), and nine putative open reading frames 
(ORFs) for accessory factors. Non-structural proteins (NSP1-16) control an array of func-
tions for survival for mature viruses. These vital functions include RNA-dependent 
polymerase (RDRp; NSP12), mRNA capping (NSPs 14 and 16), and RNA proofreading 
(NSP14) [12–15]. 
microRNAs (miRs) are short non-coding RNAs that play multifaceted roles in gene 
regulation, and also act as important regulators of the cellular antiviral response. Con-
sequently, viruses have been found to utilize the host’s nuclear RNA to evade the im-
mune response and exploit cellular machinery to their advantage by redirecting miRs to 
promote their replication [16]. In the last decade, miRs have not only been investigated 
for their diagnostic utility, but have already been applied therapeutically in different 
disease entities, for example, infection with hepatitis C virus (HCV) or oncological dis-
eases [17,18]. Furthermore, miR-mediated vaccine studies showed that a number of miRs 
have the potential to decrease viral replication with an extensive immune response [19]. 
As a proof of this understanding, viral infections alter host miRs and can cause a dra-
matic change in host responses [19]. The aspect of the miR-mediated regulation of viral 
infection is though still an emerging topic, with relatively few studies so far, and there-
fore warrants further exploration particularly also in relation to zoonotic diseases. 
Recently, we reported seven key miRs in the SARS-CoV-2 genomes that relate to 
host–pathogen interaction and viral pathogenicity, alongside a number of human 
comorbidities, and their expression was verified in miRs that are expressed in lung bi-
opsies of SARS-CoV-2 patients and in in vitro cell models in the PRJNA615032 Bioproject 
trancriptome data [20]. The seven identified miRs are spread on the SARS-CoV-2 ge-
nome, with three miRs in ORF1a and four in ORF1b, whereof two are on the spike (S) 
protein, and two on the nuclear (N) protein (Figure 1B). 
 
Figure 1. SARS-CoV-2 polycistronic genome. (A) The genome of SARS-CoV-2 organized in individual ORFs. (B) 
miR-1468, 3691, 3611, 5197, 3934, 8066, and 1307 locations on the SARS-CoV-2 genome (S spike; E envelope; M membrane; 
N nucleocapsid; NSP non-structural proteins; ORF Open reading frame). 
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Our previous study highlighted the roles of miRs in relation to SARS-CoV-2 infec-
tion and the multifaceted symptoms associated with COVID-19 [20]. While the spread of 
SARS-CoV-2 from zoonotic hosts to humans has received considerable attention, inves-
tigations into the role of miRs have hitherto been limited. Zoonotic carriers suggested for 
SARS-CoV-2 have ranged from pangolins, bats, snakes and hedgehogs, to domestic an-
imals such as pigs, ferrets, non-human primates as well as cats and dogs, while it is still 
unclear whether there is one or several carriers, and also whether the virus can jump 
species without the animals showing significant symptoms of illness [21]. In the vein of 
virus–host coevolution strategies [22,23], viruses would benefit from being in asympto-
matic carriers for their own survival, but when they jump to a species which is unfamil-
iar with the pathogen, the new host may react with severe or unexpected immune and 
other host responses to the emerging pathogen, as seen for COVID-19 in humans. 
In the current study, we hypothesize that miRs may play important roles in zoono-
sis, also forming part of virus–host coevolution. Therefore, we assessed the seven key 
miRs (miR-8066, 5197, 3611, 3934-3p, 1307-3p, 3691-3p, 1468-5p) previously identified by 
our group in the SARS-CoV-2 genome, in some of the main wild and domestic zoonotic 
species reported for human viruses, including suspected carriers for SARS-CoV-2, 
namely bat and pangolin, as well as cow, pig, chicken, and rat. 
Our findings reveal differences in miR conservation between the different suspect-
ed zoonotic carriers compared with humans, indicating possible roles for these miRs in 
viral–host coevolution, particularly highlighting pangolin, bat, cow, and pig as putative 
zoonotic carriers. This is further supported by KEGG analysis of viral and pathogenic 
pathways linked to these miRs in humans, with particular focus on the spike associated 
miR-5197, which, through nucleotide differences between pangolin and human, can 
cause the generation of three new miRs. These display tissue specificity to brain, lung, 
intestine and lymph nodes, respectively, and differ in KEGG pathway regulation, possi-
bly contributing to the adverse reaction to SARS-CoV-2 observed in the human host. 
2. Materials and Methods 
2.1. Genome Sequences 
Genome sequences obtained from NCBI for pangolin (Manis pentadactyla; 
KN008488.1), pig (Sus scrofa; NC_010453.5), cow (Bos taurus; NC_037353.1), horseshoe bat 
(Rhinolophus ferrumequinum CM014239.1), rat (Rattus norvegicus; NC_005101.4), chicken 
(Gallus gallus; NC_006089.5) and human (Homo sapiens; NC_000004.12) were searched for 
similarities with the following 7 miRs: miR-8066, 5197, 3611, 3934-3p, 1307-3p, 3691-3p, 
1468-5p, previously identified in the SARS-CoV-2 genome [20]. Sequence alignment was 
carried out using a genome-searching tool within BLASTN at NCBI. Full genome align-
ment of RaTG13 and SARS-CoV-2 (Wuhan-1 EPI_ISL_402125) was achieved using Clus-
tal Omega [24] at EBI (https://www.ebi.ac.uk/Tools/msa/clustalo/). 
2.2. Potential miR Expression and Link Analysis 
The expression levels of miRs in target cells were determined by IMOTA (Interac-
tive Multi-Omics-Tissue Atlas) [25], TissueAtlas [26], and TISSUES [27]. miRTargetLink 
for human [28] was used to analyze the potential link between miRs. Prediction of the 
RNA secondary structure in both wild type and mutated sequences for miR-5197 was 
analyzed by using the RNAfold database [29]. Minimum free energy (MFE) structures 
[30] and centroid structures [31] were calculated by the RNAfold [29]. 
2.3. Protein–Protein Network Interaction Analysis for miR Target Proteins 
Search tool for the retrieval of interacting genes/proteins (STRING) analysis 
(https://string-db.org/) was performed on target proteins identified to be regulated by 
the seven miRs under study. The protein IDs were submitted and analyzed for Gene 
Ontology (GO) and Reactome pathways. The following parameters were applied in 
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STRING: the functions selected were “search protein by the name”, and the chosen spe-
cies database was “Homo sapiens”. Network analysis was further carried out by applying 
“basic settings” and “medium confidence”. Nodes are connected by differently colored 
connecting lines, which represent interactions for the network edges, based on evidence 
as follows: “known interactions”, which are based on experimentally determined inter-
actions or curated databases; and “predicted interactions”, which are based on 
co-expression, protein homology, gene fusion, gene co-occurrence or gene neighbor-
hood, or are established by text mining. Significant levels were considered as p ≤ 0.05. 
3. Results 
3.1. Conservation of Seven SARS-CoV-2 miRs Across Zoonotic Species and Human 
To identify the putative conservation of our previously identified miR signature 
across taxa, we assessed the seven miRs in their potential source hosts, as well as in pu-
tative intermediate domestic hosts. Out of the seven miRs, miR-3611 was most strongly 
conserved across all species assessed; miR-5197 was most conserved in pangolin, pig, 
cow, bat, and rat; miR-1307 was most strongly conserved in pangolin, pig, cow, bat, and 
human; miR-3934-3p was most conserved in pig and cow, followed by pangolin and bat; 
miR-1468 was most conserved in pangolin, pig, and bat, while miR-8066 was most con-
served in pangolin and pig. In human, miR-3611 and miR-1307 were most conserved, 
while miR-8066, miR-5197, miR-3334-3p and miR-1468 were least conserved, compared 
with pangolin, pig, cow, and bat (Figure 2). 
 
Figure 2. Conservation of seven SARS-CoV-2 miRs between pangolin, pig, cow, bat, rat, chicken, and human. The con-
servation between the seven SARS-CoV-2 miR sequences, compared with the putative zoonotic species under study and 
humans. Color-coding is by E-value (sequences are provided as a Supplementary Table S1). 
3.2. Genomic Sequence Analysis 
Using genomic sequence analysis, a high similarity was seen for the seven 
SARS-CoV-2 miR sequences in both bat and human as hosts (Table 1).
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Table 1. Comparison of previously identified human miR sequences [20] in SARS-CoV-2 (human) with pangolin and bat coronaviruses. Segments extracted from multiple 
sequence alignment of complete viral genomes. Human miR sequences are identified in red; sequence differences in the other species are in green. GC content (%) and 
animal body temperature are also included in the table. 




ATATGGGTTGCAAATGAGGGAGCCTTGAATACACCTAAAGATCACATTGGCACCCGAAA 28677 Pangolin 31 32 
ATATGGGTTGCAACTGAGGGAGCCTTGAATACACCAAAAGATCACATTGGCACCCGCAAT 28723 Human 37.5 37 
ATATGGGTTGCAACTGAGGGAGCCTTGAATACACCAAAAGATCACATTGGCACCCGCAAT 28689 Bat 37.5 39–42 
5197 
CGACTCTTGACAACACATCACAGTCACTTTTGATAGTTAACAACGCAACTAATGTTATCA 21922 Pangolin 40 32 
CTACTTTAGATTCGAAGACCCAGTCCCTACTTATTGTTAATAACGCTACTAATGTTGTTA 21944 Human 48 37 
CTACCTTAGATTCGAAGACCCAGTCTCTACTTATTGTTAATAACGCTACTAATGTTGTTA 21926 Bat 43 39–42 
3611 
CAAGAGCGCTTTTTACATACTACCATCCATTGTCTCTAATGAGAAAGAAGAAATTCTTGG 4350 Pangolin 25 32 
TAAAAGTGCCTTTTACATTCTACCATCTATTATCTCTAATGAGAAGCAAGAAATTCTTGG 4371 Human 31 37 
TAAAAGTGCCTTTTACATTCTACCATCTATTATCTCTAATGAGAAGCAAGAAATTCTTGG 4353 Bat 31 39–42 
3934 
GACCCCATGCCTAATAAT---------GGCTGGACAGTCTTTTCAGCTGCTTATTACGTG 22329 Pangolin  32 
TATTTGACTCCTGGTGATTCTTCTTCAGGTTGGACAGCTGGTGCTGCAGCTTATTATGTG 22363 Human 42 37 
TATTTGACTCCTGGTGATTCTTCTTCAGGTTGGACAGCTGGTGCTGCAGCTTATTATGTG 22345 Bat 42 39–42 
1468 
ACACGTCCAACTCAGTTTGCCTGTTTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGG 360 Pangolin 42 32 
ACACGTCCAACTCAGTTTGCCTGTTTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGG 360 Human 42 37 
ACACGTCCAACTCAGTTTGCCTGTCTTACAGGTTCGCGACGTGCTCGTACGTGGCTTTGG 345 Bat 50 39–42 
1307 
TGTGTAACATTAGGGAGGACTTGAAAGAGCCACCACATTTTCACCGAGGCCACGCGGAGT 29702 Pangolin 76 32 
TGTGTAACATTAGGGAGGACTTGAAAGAGCCACCACATTTTCACCGAGGCCACGCGGAGT 29748 Human 76 37 
TGTGTAACATTAGGGAGGACTTGAAAGAGCCACCACATTTTCACCGAGGCCACGCGGAGT 29714 Bat 76 39–42 
3691 
GAGATGTTGATACAGACTTTGTGAATGAGTTTTATGCATATTTGCGTAAACACTTCTCAA 15682 Pangolin 36 32 
GAGATGTTGACACAGACTTTGTGAATGAGTTTTACGCATATTTGCGTAAACATTTCTCAA 15703 Human 41 37 
GAGATGTTGACACAGACTTTGTGAATGAGTTTTACGCATATTTGCGTAAACATTTCTCAA 15685 Bat 41 39–42 
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While miR-5197 was conserved between bat and pangolin, it nonetheless showed 
higher similarity between human and bat (Table 1). Therefore, miR-5197 was further an-
alyzed with respect to IMOTA presentation of specific genes affected by miR-5197 in a 
tissue-specific manner (Figure 3B), and was also assessed for tissue-specific distribution 
(Figure 3C). Importantly, a small change in the miR-5197 sequence in pangolin causes 
the predicted generation of three new miRs (miR-3529-5p, miR-7-1-3p and 
miR-548az-5p), which affect different KEGG signaling pathways (Figure 4). Any such 
change in new miR generation was not predicted for the other six miRs under study. 





Figure 3. Analysis of miR-5197with respect to sequence conservation and tissue distribution. (A) 
Conservation of hsa-miR-5197 in different coronavirus samples is shown in Clustal Omega multi-
ple sequence alignment (https://www.ebi.ac.uk/Tools/services/rest/clustalo/result/ 
clustalo-I20200807-161825-0106-73056325-p2m/aln-clustal_num. Selected sequences were taken 
from Ref. [32]). (B) IMOTA ((Interactive Multi-Omics-Tissue Atlas) presentation of specific genes 
affected by miR-5197 in a tissue-specific manner. (C) miR-5197 expression levels and tissue distri-
bution are shown according to tissue atlas. 









Figure 4. (A) Sequence differences between pangolin and human sequences for miR-5197 lead to the generation of three 
new miRs, which affect different signaling axes according to KEGG analysis. (B) and (C) IMOTA analysis for miR-7-1-3p 
and miR-548az-5p, respectively (IMOTA does not include miR-3529-5p); (D) Interaction networks with miR-5197, 
miR-3529-5p and miR-7-1-3p were analyzed by using miRTargetLink Human [28]. Four genes are regulated by both 
miR-5197-3p and miR-7-1-3p (NPM3, RAB10, HMGN2, TMEM167A), while CUL3 is regulated by both miR-5197-3p and 
miR-3529-5p, and VGLL4 and WASL are dependent on both miR-3529-5p and miR-7-1-3p. 
3.3. KEGG Pathway Analysis for the Three New miRs (miR-3529-5p, miR-7-1-3p, and 
miR-548az-5p) Generated by Changes in miR-5197 
While miR-5197 is implicated in KEGG pathways for p53 signaling, cancer, and 
ubiquitin-mediated proteolysis (Figure S2), a range of other KEGG pathways are associ-
ated with miR-3529-5p, miR-7-1-3p, and miR-548az-5p, with a number of overlapping, 
but also distinctive, pathways between miR-7-1-3p and miR-548az-5p, as listed in Figure 
4A, while only miR-3529-5p is associated with Mucin-O-type biosynthesis and glyco-
sphingolipid biosynthesis (Figure 4A). When assessing the tissue distribution of 
miR-7-1-3p and miR-548az-5p, some differences were observed, with miR-7-1-3p pre-
dominantly being expressed in the brain, intestinal (including esophagus) tissue, and 
muscle (Figure 4B), but miR-548az-5p in the lung, lymph nodes, and intestines (Figure 
4C). Four genes were found to be regulated by both miR-5197-3p and miR-7-1-3p 
(NPM3, RAB10, HMGN2, TMEM167A), while CUL3 is regulated by both miR-5197-3p 
and miR-3529-5p; VGLL4 and WASL are dependent on both miR-3529-5p and 
miR-7-1-3p. The gene interaction networks with the three miRs are shown in Figure 4D. 
The changes in miR-5197 sequences between pangolin and human affect the varia-
tions in RNA sequences, and were found to alter RNA secondary structure (Figure 5). 
An increase in the stability of miR-5197 in human was calculated as MFE −3.20 kcal/mol 
vs. −4.70 kcal/mol (centroid structure: −2.90 kcal/mol vs. −3.10 kcal/mol structures), and 
in pangolin as MFE (structure: −4.70 kcal/mol; centroid structure: −3.10 kcal/mol 
kcal/mol) according to the RNAfold tool 
(http://rna.tbi.univie.ac.at//cgi-bin/RNAWebSuite/RNAfold.cgi). Therefore, it can be 
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suggested that variations between SARS-CoV-2 genomes in different hosts may possibly 
lead to the generation of different structural stabilities for RNA targets. 
 
Figure 5. The impact of the divergence (given in Table 1) of miR-5197 in pangolin compared with 
human. (A) The RNA secondary structure of pangolin miR-5197 (MFE structure: −4.70 kcal/mol; 
centroid structure: −3.10 kcal/mol kcal/mol) (B) The RNA secondary structures of human miR-5197 
(MFE structure: −3.20 kcal/mol; centroid structure: −2.90 kcal/mol) using RNAfold tool. 
(http://rna.tbi.univie.ac.at//cgi-bin/RNAWebSuite/RNAfold.cgi.). 
4. Discussion 
The role of miRs in the regulation of host–pathogen interactions is still a vastly un-
derexplored topic with significant knowledge gaps in relation to human infectious dis-
ease, including zoonosis. The current study reports in silico analysis of the conservation 
of seven SARS-CoV-2-specific miRs, in six species across taxa suspected to be zoonotic 
carriers for the virus, or previously identified as zoonotic hosts for other human viruses. 
Our findings indicate that these seven SARS-CoV-2-specific miRs may possibly have 
roles in viral–host co-evolution in zoonotic hosts, particularly highlighting pangolin, bat, 
cow, and pig as putative zoonotic carriers. Furthermore, these seven miRs regulate 
genes that play important roles in viral–host interactions and other relevant cellular and 
immunological processes. KEGG and GO analyses for these miRs highlighted roles 
linked to viral pathogenicity and host responses in humans. While these pathways may 
be common to numerous viral infection responses, they possibly play significant roles in 
SARS-CoV-2, and therefore further investigations into their specificity relating to 
SARS-CoV-2 infection in particular are warranted. Interestingly, we identified that 
changes in miR-5197 nucleotide sequences between pangolin and human can generate 
three predicted new miRs (miR-3529-5p, miR-7-1-3p, and miR-548az-5p), which by bio-
informatics analysis show differing tissue distribution in brain, lung, intestine, lymph 
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nodes, and muscle, and have different downstream regulatory effects on a number of 
KEGG pathways. This may be of considerable importance as miR-5197 is localized in the 
S protein transcript area of the SARS-CoV-2 genome. 
From a total of 1594 and 1506 miRs from the Malayan and Chinese pangolin ge-
nomes, 333 have previously been reported using two complementary approaches ab ini-
tio, whereby 334 HHMMiR [33] and MiRPara [34] were shown to have similarity to the 
known miR335 genes in miRBase [35,36]. The miR sequences 336 accounted for <1% of 
the pangolin genomes, with the transposable elements-related miR-9256a-1 and 
miR-396c being 337 of the most abundant families [37]. 
Out of the seven miRs under study here, which were previously identified by us in 
the SARS-CoV-2 genome and verified to be expressed in lung biopsies of SARS-CoV-2 
patients and in vitro cell models of infected A549 and NHEB cells [20], miR-3611 was the 
most strongly conserved across all species; miR-5197 was most conserved in pangolin, 
pig, cow, bat, and rat; miR-1307 was most strongly conserved in pangolin, pig, cow, bat, 
and human; miR-3691-3p in pangolin, cow, and human; miR-3934-3p was most con-
served in pig and cow, followed by pangolin and bat; miR-1468 was most conserved in 
pangolin, pig, and bat; while miR-8066 was most conserved in pangolin and pig. In hu-
mans, miR-3611 and miR-1307 were most conserved, while miR-8066, miR-5197, 
miR-3934-3p and miR-1468 were least conserved, compared with pangolin, pig, cow, 
and bat. This indicates that pathways regulated by these different miRs may possibly 
play roles in host-tolerance, as well as in adverse reactions, indicating that the most 
conserved miRs may possibly play parts in co-evolution with the zoonotic host. On the 
other hand, following the virus jumping species, including into human, this may cause 
detrimental effects via the modulation of downstream-regulated immune and other 
metabolic pathways. When assessing Gene Ontology (GO) pathways for target genes 
and proteins affected by the different miRs, miR-3691 was linked with viral infection, 
viral mRNA translation, influenza life cycle, RNA processing and RNA metabolism 
(Figure S1). miR-5197 was related to p53 signaling, ubiquitin-mediated proteolysis, Ubl 
conjugation, and nucleic acid binding (Figure S2). The most conserved miR across all 
species, miR-3611, was associated with nucleus and cytosol (Figure S3), miR-1307 had 
strong links to spliceosome function and zinc finger proteins (Figure S4), miR-3934-3p to 
the nucleus, pre-ribosome, chromatin, and DNA pairing (Figure S5), miR-1468 to the 
regulation of RNA metabolism, gene expression, transcription, metabolism and the reg-
ulation of stress responses (Figure S6), and miR-8066 was related to mRNA splicing, the 
processing of pre-mRNA, cell cycle regulation, mTOR signaling, cell metabolism and 
macroautophagy (Figure S7). This indicates the differing functions for these various 
miRs in host–pathogen interactions, as well as in the regulation of viral transcription and 
cellular processing, downstream stress response regulation, and immune and metabolic 
functions. It can be noted that several processes listed for the various miRs above (stress 
response, viral infection life cycle and marcoautophagy) also link in with the interferon 
response [38,39], which is strongly related to viral infection [40]. Furthermore it must be 
considered that while some of these pathways relate generally to viral infection in the 
host response, the specificity of these pathways in relation to SARS-CoV-2 infection re-
mains to be investigated in relation to strategic intervention. Therefore, in relation to 
other viral infections, it may also be of interest to carry out further and similar compara-
tive analyses to aid the understanding of the disease-specific pathways mediated by 
miRs in different viral infections. 
Interestingly, out of the seven miRs under study, miR-3691-3p was found to be the 
miR with the strongest association with viral infection and viral replication, as revealed 
by Reactome pathway analysis (Figure S1) for proteins regulated by this miR, which was 
found to be conserved between pangolin, cow, and human. These findings indicate that 
cow may be a putative intermediate host between pangolin and human, but this will 
require further investigation. While pangolins have been found to have unusual re-
sistance against viral, including coronavirus, infection [41,42], the cow is also well 
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known for its unusual antiviral responses, including those via neutralizing antibodies 
(“cattlebodies”), which are effective, for example, against retroviral infections such as 
HIV [43], and are also under investigation for their effectiveness against SARS-CoV-2. 
Coronaviruses are well known in cattle and can cause gastroenteritis, respiratory dis-
ease, winter dysentery and shipping fever pneumonia [44]. Furthermore, both bovine 
and porcine respiratory coronavirus have been shown to have features in common with 
both SARS-CoV and SARS-CoV-2 [45]. 
Of putative interest was the finding that changes in miR-5197 sequences between 
humans and pangolin can lead to the generation of three new miRs, which show differ-
ences in KEGG pathway regulation. The correlation to the tissue distribution of 
miR-7-1-3p in the brain and intestine may possibly be related to some of the 
COVID-19-related symptoms observed in these organs. Furthermore, based on tissue at-
las analysis, miR-548az-5p is expressed in the lung, lymph nodes, and intestines, all of 
which are significant target organs in COVID-19. This may indicate that these miRs, due 
to a lack of co-evolution with the virus as is possibly observed in pangolin, may ad-
versely affect the human host in these specific sites. This may furthermore be of im-
portance as miR-5197 is on the spike region of the SARS-CoV-2 genome, and therefore 
this diversification of miR-5197 may possibly aid its regulatory activities in the distinct 
tissue types, consequently affecting downstream KEGG pathways. miR-5197 is critical 
for mucin-type O-glycan biosynthesis pathways, which relate to both human and veter-
inary viral infections, including HTLV-1, Ebola, HIV-1, HSV-1, avian influenza, and 
avian oncogenic retrovirus [46–51]. miR-5197 is also related to the KEGG morphine ad-
diction pathway, which is linked to enhanced HIV-1 infection, HCV replicon expression, 
the reduced clearance of pulmonary influenza virus infection in rats, and increased SA-
IDS in rhesus monkeys [52–57]. miR-5197 furthermore influences the metabolism of xe-
nobiotics by cytochrome P450 mechanisms and the TGF-β signaling pathway, which is 
associated with viral entry and HIV infection [58] and is strongly linked to both pulmo-
nary and cardiovascular diseases [59–61]. Furthermore, miR-5197 is related to p53 regu-
latory pathways and cancers, ubiquitin-related proteolysis, and molecular and cellular 
GO pathways linked to nucleic acid binding and to nuclear and organelle function (Fig-
ure S2) (please see further in depth discussion on these pathways in Ref. [20]). 
Four genes that were identified to be regulated by both miR-5197-3p and 
miR-7-1-3p were NPM3, RAB10, HMGN2, and TMEM167A. NPM3 has roles in ribosome 
biogenesis, chromatin remodeling, the protein and histone chaperone function, and the 
RNA-binding activity of nucleolar phosphoprotein B23/NPM [62,63]. It has furthermore 
been linked to lung papillary adenocarcinoma [64]. RAB10 is a small GTPase and regu-
lates intracellular vesicle trafficking [65], and has been linked to Legionella pneumophila 
infection and replication [66]. HMGN2 binds nucleosomal DNA and is associated with 
transcriptionally active chromatin; it furthermore has antimicrobial activity against bac-
teria, viruses, and fungi [67,68], while specific roles in SARS-CoV-2 infection remain to 
be investigated. TMEM167A is involved in the early part of the secretory pathway, and 
is a regulator of vesicular trafficking [69,70]. CUL3 was identified to be regulated by 
both miR-5197-3p and miR-3529-5p; importantly, it has roles in endothelial cell function 
and angiogenesis [71], which may be of interest in relation to the strong endotheli-
al-related responses observed in COVID-19. CUL3 also plays roles in protein homodi-
merization activities and ubiquitin–protein transferase activity, as well as in oxidative 
and electrophilic stress [13]. VGLL4 and WASL were identified to be dependent on both 
miR-3529-5p and miR-7-1-3p. VGLL4 is an inhibitor of cell proliferation and can act as a 
tumor suppressor, including via T-cell-mediated responses [72], and is also linked to 
meningioma and Wilson–Turner X-linked mental retardation syndrome 
(https://www.genecards.org/cgi-bin/carddisp.pl?gene=VGLL4). WASL regulates nuclear 
actin in transcriptional regulation [73], as well as actin cytoskeletal organization, includ-
ing in filopodia formation and during actin remodeling for evasion strategies of 
NK-cell-mediated killing [74–77]. Importantly, WASL has also been found to facilitate 
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cellular entry for a range of picornaviruses [74], while its importance in SARS-CoV-2 in-
fection mechanisms needs verification. Diseases associated with WASL include Wiskott–
Aldrich Syndrome (eczema-thrombocytopenia-immunodeficiency syndrome) [78], and 
WASL’s regulation of actin in the host is modified in Mycobacterium-mediated Buruli ul-
cers [79], pointing to its various roles in immune regulation and host–pathogen interac-
tions. 
Of interest, we have also noted the difference in GC content in the miR sequences 
between taxa in the putative zoonotic hosts, compared with human. As body tempera-
ture differs between human and these zoonotic hosts, it may be speculated that this can 
have some implications on miR function in the different species, as temperature is in-
deed an important factor for annealing, with higher GC content reflecting higher tem-
perature tolerance. Interestingly, the higher GC content was reported to be from more 
stable duplexes with their targets [80]. In this context, the normal body temperature of 
the pangolin is 32 °C, while in bat this is 39–42 °C, the adult cow is around 38.5 °C, pig is 
around 38.7 °C, that of rat is 35.9 to 37.5 °C. and in adult chicken it is 40.6 °C to 41.7 °C. 
Previously, it has been discussed that the higher body temperature and increased me-
tabolism in bats may serve as an evolutionary aid for their immune system by providing 
a powerful fight during viral infections [81]. Moreover, the stability of the miR–target 
interaction shows a negative correlation with body temperature; in other words, lower 
GC contents at higher body temperatures result in less functional stability in miR–
mRNA interactions [82,83]. Furthermore, as the calculated stability of miR-5197 in the 
human differed from that of pangolin, this may suggest that possible variations between 
SARS-CoV-2 genomes in different hosts may lead to the generation of different structur-
al stabilities in RNA targets. 
Indeed, various zoonotic hosts for SARS-CoV-2 have been discussed in the litera-
ture during the current COVID-19 pandemic, but also in relation to the previous 
SARS-CoV outbreaks. This has pointed to the involvement of, for example, bats, snakes, 
and pangolins, but also, as many viruses jump from wild to domestic animals, some-
times having multiple hosts, due to the disruption of ecological balance and habitat 
shifts caused by anthropogenic activities, there are a number of domestic and compan-
ion animals that may need to be considered, particularly as these will be in close contact 
with humans [84,85]. As SARS-CoV-2 has indeed been reported in domestic species, 
such as felines and canines, we have in the current study, besides bat and pangolin, also 
assessed the seven miRs in cow, pig, chicken, and rat as exemplar domestic species, 
which have historically been linked to a range of zoonotic diseases. In this context, the 
recent SARS-CoV-2 transmission to mink on Danish mink farms further emphasizes the 
adaptability of this zoonotic virus, and the risk of species-jumping and transmission 
caused by anthropogenic changes. 
The aspect of miR-mediated regulation in viral infection is an emerging topic, with 
relatively few studies so far in relation to human host responses, and it therefore war-
rants further exploration, particularity also in relation to zoonotic disease, including in 
wild and domestic species. Therefore, our identification here of differences in the con-
servation of the seven SARS-CoV-2-specific miRs previously identified in human in the 
several candidate zoonotic carriers under study, compared with human, may contribute 
to furthering understanding of the miR-mediated regulation of virus–host coevolution, 
and its roles in zoonotic disease spread and tolerance between species. Such 
miR-mediated regulation also may help to further understand some of the detrimental 
effects observed in human host immune responses when encountering new zoonotic 
pathogens. 
With this in silico study we hope to pave the way for furthering research into the 
regulatory roles of miRs in zoonosis. Targeting miRs in emerging infectious diseases 
may be a promising novel strategy for therapeutic intervention. 
  




The role of microRNAs in the regulation of host–pathogen interactions is a vastly 
underexplored topic with significant knowledge gaps in relation to human infectious 
disease, including zoonosis. The current study reports the conservation of seven 
SARS-CoV-2-specific microRNAs in six species across taxa suspected to be zoonotic car-
riers for the virus, or previously identified as zoonotic hosts for other human viruses. 
Our in silico analysis indicates that these SARS-CoV-2-specific miRs may play possible 
roles in viral–host co-evolution in a number of zoonotic hosts, particularly highlighting 
pangolin, bat, cow, and pig as putative zoonotic carriers. Our findings may contribute to 
the current understanding of some of the detrimental effects observed by human host 
immune responses when encountering new zoonotic pathogens, and pave the way for 
further investigations into the roles of miRs in zoonosis. Targeting miRs in emerging in-
fectious diseases may be a promising strategy for novel therapeutic intervention, which 
warrants further investigation. 
Supplementary Materials: The following are available online at www.mdpi.com/xxx/s1, Figure 
S1, Reactome pathways for miR-3691-regulated target proteins. Target genes for miR-3691 were 
identified using miR base and interaction networks generated using STRING analysis. Reactome 
pathways (A,B), KEGG pathways (C), UniProt keywords (D) and molecular function GO path-
ways (E) are highlighted in the different color nodes, see color key in the figure. Known and pre-
dicted interactions are indicated by differently colored lines (see color key in figure). Figure S2, 
Interaction pathways for miR-5197-regulated target proteins. Target genes for miR-5197 were 
identified using miR base and interaction networks generated using STRING analysis. The fol-
lowing pathways are highlighted: (A) KEGG pathways; (B) UniProt keywords; (C) Molecular GO 
function; (D) Cellular GO pathways. The individual pathways are highlighted in the different col-
or nodes, see color key in the figure. Known and predicted interactions are indicated by differently 
colored lines (see color key in figure). Figure S3, Interaction pathways for miR-3611-regulated tar-
get proteins. Target genes for miR-3611 were identified using miR base and interaction networks 
generated using STRING analysis. The following pathways are highlighted: (A) Cellular GO 
component; (B) Biological GO process. The individual pathways are highlighted in the different 
color nodes, see color key in the figure. Known and predicted interactions are indicated by differ-
ently colored lines (see color key in figure). Figure S4, Interaction pathways for 
miR-1307-regulated target proteins. Target genes for miR-1307 were identified using miR base and 
interaction networks generated using STRING analysis. The following pathways are highlighted: 
(A) Cellular GO component; (B) PFAM protein domains; (C) INTERPRO protein domains; (D) 
SMART protein domains. The individual pathways are highlighted in the different color nodes, 
see color key in the figure. Known and predicted interactions are indicated by differently colored 
lines (see color key in figure). Figure S5, Interaction pathways for miR-3934-regulated target pro-
teins. Target genes for miR-1307 were identified using miR base and interaction networks gener-
ated using STRING analysis. The following pathways are highlighted: (A) Cellular GO compo-
nent; (B) Reactome pathways. The individual pathways are highlighted in the different color 
nodes, see color key in the figure. Known and predicted interactions are indicated by differently 
colored lines (see color key in figure). Figure S6, Interaction pathways for miR-1468-regulated tar-
get proteins. Target genes for miR-1468 were identified using miR base and interaction networks 
generated using STRING analysis. The following pathways are highlighted: (A) Biological GO 
process; (B) Cellular GO component. The individual pathways are highlighted in the different col-
or nodes, see color key in the figure. Known and predicted interactions are indicated by differently 
colored lines (see color key in figure). Figure S7, Interaction pathways for miR-8066-regulated tar-
get proteins. Target genes for miR-1468 were identified using miR base and interaction networks 
generated using STRING analysis. The following pathways are highlighted: (A) Reactome path-
ways; (B) Biological GO process; (C) Cellular GO component. The individual pathways are high-
lighted in the different color nodes, see color key in the figure. Known and predicted interactions 
are indicated by differently colored lines (see color key in figure). Table S1, The conservation be-
tween the seven SARS-CoV-2 miR sequences, compared with the putative zoonotic species under 
study and humans. 
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